Every commercial leader I talk to at major industry events, whether it is the DIA Annual Meeting in Washington D.C., BIO International Convention in Boston, or ISPOR’s global conference, tells me the same story. They have more data than ever. Dashboards everywhere. And yet, when it comes to answering the questions that actually matter- which […]
Most of the conversations our Life Sciences team has with biopharma leaders do not start with technology. They start with frustration. A commercial or operations leader describes a supply chain that looks orderly on an org chart and behaves like a guessing game in practice, and within the first ten minutes the real issue surfaces: […]
Infocepts Pharma AI Insights Series In today’s fast-evolving healthcare landscape, 40% of interactions with healthcare professionals (HCPs) miss the mark—delivering the wrong message, at the wrong time, through the wrong channel. For pharmaceutical and MedTech companies, these missed opportunities translate into $2–3 billion in lost sales annually. The cost is not just financial. Ineffective engagement […]
Infocepts Pharma AI Insights Series AI is no longer an experimental tool in healthcare — it is actively reshaping how pharmaceutical companies work, compete, and care. Leaders like Bayer, Medtronic, and AstraZeneca are already advancing on IMD’s AI Maturity Index, using AI not only for drug discovery but also for listening, learning, and leading with […]
